Section 721.11137 - Oxirane, 2-alkyl-, polymer with oxirane, mono[N-[3-(carboxyamino)-4(or 6)-alkylphenyl] carbamate], alkyl ether, ester with 2,2',2"-nitrilotris-[alkanol] (generic)(a)Chemical substance and significant new uses subject to reporting.(1) The chemical substance identified generically as oxirane, 2-alkyl-, polymer with oxirane, mono[N-[3-(carboxyamino)-4(or 6)-alkylphenyl]carbamate], alkyl ether, ester with 2,2',2"-nitrilotris-[alkanol] (PMN P-17-230) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section. The requirements of this section do not apply to quantities of the substance after they have been reacted (cured).(2) The significant new uses are: (i)Protection in the workplace. Requirements as specified in § 721.63(a)(1), (a)(2)(i) and (iii), (a)(3), (a)(6)(v) (particulate (including solids or liquid droplets)), (when determining which persons are reasonably likely to be exposed as required for § 721.63(a)(1) , engineering control measures (e.g., enclosure or confinement of operation, general and local ventilation) or administrative control measures (e.g., workplace policies and procedures) shall be considered and implemented to prevent exposure, where feasible), (b) (concentration set at 1.0%), and (c).(ii)Hazard communication. Requirements as specified in § 721.72(a) through (e) (concentration set at 1.0%), (f), (g)(1)(i), (ii), (eye irritation), (g)(2)(i), (ii), and (v), (g)(3)(i) and (ii), and (g)(5). Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA Hazard Communication Standard may be used.(iii)Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(f), (k), and (q) . It is a significant new use to modify processing methods if such modification would result in inhalation exposures to the chemical substance by vapor, dust, mist, or aerosol, at a concentration of greater than 1.0% by weight or volume. It is a significant new use to use the chemical substance in the confidential formulation at a concentration greater than 1.0% by weight or volume. It is a significant new use to manufacture, process, or use the substance for consumer use or for commercial uses that could introduce the substance into a consumer setting.(iv)Release to water. Requirements as specified in § 721.90(a)(4), (b)(4), and (c)(4) where N = 65.(b)Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph (b). (1)Recordkeeping. Recordkeeping requirements as specified in § 721.125(a) through (i) and (k) are applicable to manufacturers and processors of this substance.(2)Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this section.(3)Determining whether a specific use is subject to this section. The provisions of § 721.1725(b)(1) apply to paragraph (a)(2)(iii) of this section.84 FR 55063, Oct. 15, 2019 83 FR 47021, 11/16/2018; 84 FR 55063, 12/16/2019